KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardelyx (ARDX) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Ardelyx (ARDX) over the last 12 years, with Q3 2025 value amounting to $482000.0.

  • Ardelyx's Gains from Investment Securities rose 5015.58% to $482000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 33188.12%. This contributed to the annual value of $1.0 million for FY2024, which is 19793.51% up from last year.
  • Per Ardelyx's latest filing, its Gains from Investment Securities stood at $482000.0 for Q3 2025, which was up 5015.58% from $1.7 million recorded in Q2 2025.
  • Ardelyx's 5-year Gains from Investment Securities high stood at $13.9 million for Q2 2021, and its period low was -$12.8 million during Q4 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was $320500.0 (2023), whereas its average is $457562.5.
  • Per our database at Business Quant, Ardelyx's Gains from Investment Securities crashed by 5000000.0% in 2023 and then soared by 22120000.0% in 2025.
  • Over the past 5 years, Ardelyx's Gains from Investment Securities (Quarter) stood at -$12.8 million in 2021, then surged by 101.41% to $180000.0 in 2022, then soared by 77.78% to $320000.0 in 2023, then grew by 0.31% to $321000.0 in 2024, then surged by 50.16% to $482000.0 in 2025.
  • Its last three reported values are $482000.0 in Q3 2025, $1.7 million for Q2 2025, and $2.2 million during Q1 2025.